Bruno Rezende Souza

Bruno Rezende Souza

Auto-generated profile, based on publicly available information

Bruno Rezende Souza

Laboratório de Neurodesenvolvimento e Evolução, Department of Physiology and Biophysics, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil, 31270-901

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2011 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
BSBruno Rezende Souza
Bruno Rezende Souza
MRMarco Romano-Silva
Marco Romano-Silva
VTVincent Tropepe
Vincent Tropepe
An imbalance in dopamine-mediated neurotransmission is a hallmark physiological feature of neuropsychiatric disorders, such as schizophrenia. Recent evidence demonstrates that dopamine D2receptors, which are the main target of antipsychotics, modulate the activity of the protein kinase Akt, which is known to be downregulated in the brain of patients with schizophrenia. Akt has an important role in the regulation of cellular processes that are critical for neurodevelopment, including gene transcription, cell proliferation, and neuronal migration. Thus, it is possible that during brain development, altered Akt-dependent dopamine signaling itself may lead to defects in neural circuit formation. Here, we used a zebrafish model to assess the direct impact of altered dopamine signaling on brain development and larval motor behavior. We demonstrate that D2receptor activation acutely suppresses Akt activity by decreasing the level of pAkt(Thr308) in the larval zebrafish brain. This D2-dependent reduction in Akt activity negatively regulates larval movement and is distinct from a D1-dependent pathway with opposing affects on motor behavior. In addition, we show that D2-dependent suppression of Akt activity causes a late onset change in GSK3b activity, a known downstream target of Akt signaling. Finally, altered D2receptor signaling, or direct inhibition of Akt activity, causes a significant decrease in the size of the GABAergic neuron population throughout most of the brain. Our observations suggest that D2receptor signaling suppresses Akt-GSK3b activity, which regulates GABAergic neuron development and motor behavior.

1 February 2011 in Reviews in the Neurosciences
Verified
Journal Article
Closed access
BSBruno Rezende Souza
Bruno Rezende Souza
VTVincent Tropepe
Vincent Tropepe
Neurodevelopment depends on intrinsic and extrinsic factors that influence the overall pattern of neurogenesis and neural circuit formation, which has a direct impact on behaviour. Defects in dopamine signalling and brain morphology at a relatively early age, and mutations in neurodevelopmental genes are strongly correlated with several neuropsychiatric disorders. This evidence supports the hypothesis of a neurodevelopmental origin of at least some forms of mental illness. Zebrafish (Danio rerio) has emerged as an important vertebrate model system in biomedical research. The ease with which intrinsic and extrinsic factors can be altered during early development, the relatively conserved dopaminergic circuit organisation in the larval brain, and the emergence of simple sensorimotor behaviours very early in development are some of the appealing features that make this organism advantageous for developmental brain and behaviour research. Thus, examining the impact of altered dopamine signalling and disease related genetic aberrations during zebrafish development presents a unique opportunity to holistically analyse thein vivobiochemical, morphological and behavioural significance of altered dopamine signalling during a crucial period of development using a highly tractable vertebrate model organism. Ultimately, this information will shed new light on potential therapeutic targets for the treatment of schizophrenia and perhaps serve as a paradigm for investigating the neurodevelopmental origin of other psychiatric disorders.

1 March 2009 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
KTK.C.L. Torres
K.C.L. Torres
BSB.R. Souza
B.R. Souza
DMDebora De Miranda
Debora De Miranda
RNR. Nicolato
R. Nicolato
FNF.S. Neves
F.S. Neves
MRMarco Romano-Silva
Marco Romano-Silva

1 March 2009 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
KTK.C.L. Torres
K.C.L. Torres
BSB.R. Souza
B.R. Souza
DMDebora De Miranda
Debora De Miranda
ASA.M. Sampaio
A.M. Sampaio
RNR. Nicolato
R. Nicolato
MRMarco Romano-Silva
Marco Romano-Silva

1 June 2012 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
GBGustavo E.A. Brito-Melo
Gustavo E.A. Brito-Melo
RNRodrigo Nicolato
Rodrigo Nicolato
AOAntonio Carlos P. de Oliveira
Antonio Carlos P. de Oliveira
GMGustavo B. Menezes
Gustavo B. Menezes
FLFelipe J.N. Lélis
Felipe J.N. Lélis
HRHelton José Reis
Helton José Reis

16 December 2016 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
KAK. A. F. de Alvarenga
K. A. F. de Alvarenga
ESE. K. Sacramento
E. K. Sacramento
DRD. V. Rosa
D. V. Rosa
BSB. R. Souza
B. R. Souza
VRV. B. de Rezende
V. B. de Rezende
MRMarco Romano-Silva
Marco Romano-Silva